曾感染B型肝炎病毒不影響rituximab治療類風濕性關節炎的成效：回溯性研究 Previous hepatitis B virus infection does not affect the effectiveness of rituximab in the treatment of rheumatoid arthritis: A retrospective study
風濕性疾病患者之需要機械通氣的肺囊蟲肺炎的預後與相關因素之探討 Outcomes and Prognostic Factors related to Pneumocystis Pneumonia Requiring Mechanical Ventilation in Patients with Rheumatic Diseases
過敏性紫斑症的臨床表現與預後，比較兒童與成人的差異 The Clinical Manifestations and Outcomes of Henoch-Schönlein Purpura: Differences between Children and Adults
紅斑性狼瘡患者合併冠狀動脈心臟疾病或肺動脈高壓的特徵差異──單一醫學中心回溯性研究 Differences between Coronary Artery Disease and Pulmonary Arterial Hypertension in Patients with Systemic Lupus Erythematosus--A Single-Center Retrospective Study
類風溼關節炎患者之莫須瘤輸注反應危險因子：單一中心五年459次輸注經驗探討 Risk factor of infusion-related reactions of rituximab in rheumatoid arthritis: single-center experience of 459 infusions over 5 years
類風濕關節炎患者接受生物製劑及口服小分子標靶藥物後產生之嗜酸性球增多症 The emergence of eosinophilia in patients with rheumatoid arthritis receiving therapy with biological agents or JAK inhibitor
具有Ku抗體的風濕疾病病人之臨床特徵：臺灣單一醫學中心之回顧性研究 Clinical Characteristics of Rheumatic Patients with Anti-Ku Antibodies: A Retrospective Study in a Medical Center in Taiwan
以多處局部皮膚腫脹為初始表現並帶有AC-6（多核點）ANA形態病患之三年期追蹤 Three years follow up of a patient initially presented with multifocal swelling skin lesions with AC-6(multiple nuclear dots) ANA pattern
